{
  "schemaVersion": 1,
  "id": "research-089",
  "slug": "089-how-researchers-defined-hormone-selectivity-for-ipamorelin",
  "title": "How researchers defined hormone selectivity for ipamorelin",
  "catalogLabel": "CJC-1295 (No DAC) / Ipamorelin",
  "productCollection": "https://heritagebiolabs.com/research-library/products/cjc-1295-no-dac-ipamorelin",
  "productHandles": [
    "cjc-1295-ipamorelin-578"
  ],
  "productUrls": [
    "https://heritagebiolabs.com/product/cjc-1295-ipamorelin-578"
  ],
  "readingFocus": "Mechanisms & biology",
  "readingFocusNote": "Reading focus is a navigational tag, not an evidence grade.",
  "wordCount": 274,
  "sourceYears": [
    1998,
    2024
  ],
  "paragraphs": [
    "Short amino-acid chains held together by peptide bonds can act on receptors that influence more than one hormone. The label CJC-1295 (No DAC) / Ipamorelin refers to modified growth hormone–releasing factor (1–29) alongside a synthetic five-residue growth hormone secretagogue. In the original ipamorelin research, what did it mean to describe the compound as selective? [1, 2]",
    "In a 1998 preclinical study, researchers used rat pituitary cells and animal experiments to compare ipamorelin with related peptides. In the cell experiments, ipamorelin stimulated growth hormone release through a growth hormone secretagogue–type receptor. In pigs, GHRP-2 and GHRP-6 increased two additional hormones, adrenocorticotropic hormone and cortisol. The researchers did not observe a significant difference between ipamorelin and the GHRH comparison for those two endpoints in the pig experiment. [2]",
    "That is a comparison among named compounds, for measured hormones, in a specific species. It gives context for the term selective. It leaves open what would happen to other biological processes or with a different exposure, and does not establish that ipamorelin's selectivity in pigs would hold for a mixture in humans. A trial interested in selectivity would need to measure the hormones it claims to distinguish. [2, 3]",
    "No recent primary study of the exact no-DAC and ipamorelin combination was identified for this question. The older work studied ipamorelin by itself and compared it with several reference compounds. Its design helps identify which observations justify a claim about a single peptide. The FDA's later review identifies gaps in the available clinical effectiveness and safety evidence for ipamorelin itself. A response observed in swine is a reason to test human selectivity directly under defined conditions. [1, 2, 3]"
  ],
  "sources": [
    {
      "number": 1,
      "citation": "U.S. Food and Drug Administration. December 4, 2024 Pharmacy Compounding Advisory Committee (PCAC) Meeting. FDA briefing document on CJC-1295-related bulk drug substances (publication 2024-12-04).",
      "url": "https://www.fda.gov/media/183819/download"
    },
    {
      "number": 2,
      "citation": "Raun K et al. Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology (publication 1998-11).",
      "url": "https://pubmed.ncbi.nlm.nih.gov/9849822/"
    },
    {
      "number": 3,
      "citation": "U.S. Food and Drug Administration. October 29, 2024 Meeting of the Pharmacy Compounding Advisory Committee. FDA briefing document on ipamorelin-related bulk drug substances (publication 2024-10-29).",
      "url": "https://www.fda.gov/media/182088/download"
    }
  ],
  "canonicalUrl": "https://heritagebiolabs.com/research-library/articles/089-how-researchers-defined-hormone-selectivity-for-ipamorelin",
  "markdownUrl": "https://heritagebiolabs.com/research-library/data/articles/089-how-researchers-defined-hormone-selectivity-for-ipamorelin.md",
  "jsonUrl": "https://heritagebiolabs.com/research-library/data/articles/089-how-researchers-defined-hormone-selectivity-for-ipamorelin.json",
  "provenance": {
    "sourceArchive": "Peptide Research Articles - All 82 Volumes.zip",
    "sourceArchiveSha256": "9796bec477cbe2f8017dda81c7e58260985a13bdda1f934e8eb8d0549c2cada5",
    "sourceVolume": "Peptide Research Articles 018 - CJC-1295 (No DAC) Ipamorelin.docx",
    "sourceArticleNumber": 89,
    "contentSha256": "d7daf29e5e50073ba17e958795df9bf91e46d6fc2453a8d645d8156a306e368d",
    "statement": "Article titles, body paragraphs and numbered citations extracted without rewriting from owner-supplied Word volumes. Product mappings use exact catalog labels; reading-focus tags and excerpts are navigational metadata. No independent peer-review or comprehensive source verification is claimed."
  },
  "scope": "Educational article about published research. For research use only; not medical advice. Literature does not establish the identity, purity or activity of a purchased lot, and studies of individual components do not validate a blend."
}
